Platinum drugs and taxanes: can we overcome resistance?
Open Access
- 26 June 2021
- journal article
- review article
- Published by Springer Science and Business Media LLC in Cell Death Discovery
- Vol. 7 (1), 1-10
- https://doi.org/10.1038/s41420-021-00554-5
Abstract
Cancer therapy is aimed at the elimination of tumor cells and acts via the cessation of cell proliferation and induction of cell death. Many research publications discussing the mechanisms of anticancer drugs use the terms “cell death” and “apoptosis” interchangeably, given that apoptotic pathways are the most common components of the action of targeted and cytotoxic compounds. However, there is sound evidence suggesting that other mechanisms of drug-induced cell death, such as necroptosis, ferroptosis, autophagy, etc. may significantly contribute to the fate of cancer cells. Molecular cross-talks between apoptotic and nonapoptotic death pathways underlie the successes and the failures of therapeutic interventions. Here we discuss the nuances of the antitumor action of two groups of the widely used anticancer drugs, i.e., platinum salts and taxane derivatives. The available data suggest that intelligent interference with the choice of cell death pathways may open novel opportunities for cancer treatment.Keywords
This publication has 132 references indexed in Scilit:
- The pharmacological bases of the antiangiogenic activity of paclitaxelAngiogenesis, 2013
- The role of nuclear lamin B1 in cell proliferation and senescenceGenes & Development, 2011
- Autophagy: Renovation of Cells and TissuesCell, 2011
- P73 regulates cisplatin-induced apoptosis in ovarian cancer cells via a calcium/calpain-dependent mechanismOncogene, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Therapy-Induced Senescence in CancerJNCI Journal of the National Cancer Institute, 2010
- The cell cycle and acute kidney injuryKidney International, 2009
- Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2Current Opinion in Cell Biology, 2009
- An E2F1-Dependent Gene Expression Program that Determines the Balance between Proliferation and Cell DeathCancer Cell, 2008
- The Hallmarks of CancerCell, 2000